Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dyadic International (DYAI)

Dyadic International (DYAI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dyadic to Attend Three Upcoming Investor Conferences in October

JUPITER, FL / ACCESSWIRE / October 10, 2019 / Dyadic International, Inc. (the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene...

DYAI : 6.48 (-0.77%)
Dyadic to Present at Janney Healthcare Conference

JUPITER, FL / ACCESSWIRE / September 4, 2019 / Dyadic International, Inc. (the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene...

DYAI : 6.48 (-0.77%)
Dyadic to Present at Four Upcoming Investor Conferences in September

JUPITER, FL / ACCESSWIRE / August 21, 2019 / Dyadic International, Inc. (the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.48 (-0.77%)
Dyadic Reports Second Quarter 2019 Results and Recent Developments

Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower...

FSNN : 0.0580 (-19.44%)
DYAI : 6.48 (-0.77%)
Dyadic to Report Second Quarter 2019 Financial Results on Tuesday August 13, 2019

JUPITER, FL / ACCESSWIRE / July 30, 2019 / Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.48 (-0.77%)
OTC Markets Group Announces Quarterly Index Performance and Rebalancing

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the second quarter 2019 performance and quarterly rebalancing of the OTCQX® and...

DYAI : 6.48 (-0.77%)
FDMQY : 0.5200 (-14.75%)
BBXTB : 4.2500 (-6.59%)
DUOT : 0.4700 (unch)
IEHC : 20.0000 (+2.25%)
ACRGF : 5.9700 (-1.81%)
SMICY : 6.1600 (-0.40%)
CBBI : 10.6000 (unch)
CBWA : 13.8400 (+1.02%)
CTUY : 30.5000 (+3.18%)
DBIN : 32.6000 (-1.51%)
ENBP : 20.2000 (-0.74%)
FNBT : 25.1000 (unch)
IBTN : 16.2500 (+1.06%)
KTYB : 23.1200 (-0.94%)
LYBC : 38.7500 (+1.95%)
MNMB : 39.8500 (-1.12%)
PFLC : 11.4000 (unch)
RYFL : 16.0000 (-1.84%)
SVBT : 79.5100 (-0.29%)
WRIV : 66.3700 (+0.11%)
AMXEF : 0.7900 (-9.38%)
CTSDF : 0.7130 (-1.56%)
AGEEF : 0.2100 (-4.55%)
HERTF : 0.2312 (+0.52%)
MEDIF : 3.3100 (-0.30%)
NXGWF : 0.1199 (-16.10%)
PLNHF : 1.6345 (-2.13%)
RDDTF : 0.4305 (-3.56%)
ALXDF : 0.0398 (-0.50%)
DYMEF : 0.0848 (+24.71%)
OTCM : 34.2600 (-0.26%)
Dyadic Extends Research and Development Agreement with VTT

JUPITER, FLORIDA / ACCESSWIRE / July 5, 2019 / Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global platform biotechnology company, announced today that it has extended its research...

DYAI : 6.48 (-0.77%)
Dyadic Joins Russell Microcap(R) Index

JUPITER, FL / ACCESSWIRE / July 2, 2019 / Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary...

DYAI : 6.48 (-0.77%)
Dyadic Announces Appointment of Ping Rawson to CFO

JUPITER, FL / ACCESSWIRE / June 27, 2019 / Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.48 (-0.77%)
Dyadic to Present at the 20th Annual B. Riley FBR Investor Conference and Upcoming Industry Events

JUPITER, FL / ACCESSWIRE / May 17, 2019 / Dyadic International, Inc. (the ''Company'') (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.48 (-0.77%)
Dyadic Reports First Quarter 2019 Financial Results and Recent Developments

Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower...

FSNN : 0.0580 (-19.44%)
DYAI : 6.48 (-0.77%)
Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines

PUNE, INDIA and JUPITER, FL / ACCESSWIRE / May 8, 2019 / Dyadic International, Inc. (''Dyadic'') (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary...

DYAI : 6.48 (-0.77%)
New Gene Therapies Hold Out Promise for Patients

Gene therapies are gaining growing attention within the medical sector.

NVS : 86.88 (-0.40%)
ONCE : 100.04 (-0.94%)
TROV : 1.05 (-2.78%)
DYAI : 6.48 (-0.77%)
Dyadic Announces Sub-Licensing Agreement with Alphazyme

JUPITER, FL / ACCESSWIRE / May 6, 2019 / Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.48 (-0.77%)
Dyadic to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019

JUPITER, FL / ACCESSWIRE / April 25, 2019 / Dyadic International, Inc. ("Dyadic") (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.48 (-0.77%)
Dyadic Announces Uplisting to the Nasdaq Capital Market

JUPITER, FL / ACCESSWIRE / April 15, 2019 / Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...

DYAI : 6.48 (-0.77%)
OTC Company Investor Presentations Now Available for On-Demand Viewing

Virtual Investor Conferences, the leading proprietary investor conference series, announced that the presentations from the April 4th, 2019 conference are now available for on-demand viewing at VirtualInvestorConferences.com....

FLY.VN : 1.250 (+3.31%)
AXV.VN : 0.400 (+5.26%)
PYR.VN : 0.540 (unch)
SMID : 7.6000 (-1.30%)
DYAI : 6.48 (-0.77%)
BFGC : 0.1600 (unch)
WDLF : 0.1150 (-4.09%)
Dyadic International to Webcast, Live, at VirtualInvestorConferences.com April 4th

Dyadic International, Inc. (the "Company") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to speed up the development, lower...

DYAI : 6.48 (-0.77%)
Live Investor Conference & Webinar April 4th

Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series. Individual investors, institutional investors,...

FLY.VN : 1.250 (+3.31%)
AXV.VN : 0.400 (+5.26%)
PYR.VN : 0.540 (unch)
SMID : 7.6000 (-1.30%)
DYAI : 6.48 (-0.77%)
WDLF : 0.1150 (-4.09%)
BFGC : 0.1600 (unch)
Dyadic Reports 2018 Year End Results and Recent Developments

/ Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development,...

FSNN : 0.0580 (-19.44%)
MTZPY : 11.3300 (-1.65%)
QUOT : 8.04 (-1.59%)
DYAI : 6.48 (-0.77%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +4.48 , AIZ -0.27 , SBAC +4.06 , SO +0.08 , WELL +0.91
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar